Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Michael Studnicka"'
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 90(3)
Recently the superiority of Crizotinib to standard first-line pemetrexed-plus-platinum chemotherapy in patients with previously untreated advanced ALK-positive NSCLC has been demonstrated. We report of a 36-year-old never smoker with advanced squamou